TECHNOLOGY NEWS
Untitled Page
Visual-tech firm Christie enters the medical world
Cypress-based firm acquires assets from Luminetx, forms health products business.
By Kristen SchottPublished: January 06, 2010 11:13 AM
Cypress-based visual technology firm Christie is expanding its business into the medical field. The company has acquired assets for an undisclosed amount from Luminetx Corp., including the technology for VeinViewer, the company's vascular imaging system.
With the new innovations, Christie will create a medical products business that will run under Christie Medical Holdings. The firm says it will combine the strength of the VeinViewer, along with its own experience in the visual technology field, in the new operation.
“We’re excited by the potential of this acquisition,” says Christie Medical President George Pinho. “Christie’s goal is to diversify into emerging markets, and we saw a unique opportunity to enter the medical imaging industry.”
The VeinViewer uses near-infrared light to find a patient's veins through the skin. After finding the veins, it projects a real-time image of their location onto the skin.
NEXT PAGE >>
Related headlines
Hoag expands service with Skylight extension
Irvine’s Cardiogenesis submits device to FDA
UCI study: Type two diabetics need specific treatment
|
||||
|
With the new innovations, Christie will create a medical products business that will run under Christie Medical Holdings. The firm says it will combine the strength of the VeinViewer, along with its own experience in the visual technology field, in the new operation. “We’re excited by the potential of this acquisition,” says Christie Medical President George Pinho. “Christie’s goal is to diversify into emerging markets, and we saw a unique opportunity to enter the medical imaging industry.” The VeinViewer uses near-infrared light to find a patient's veins through the skin. After finding the veins, it projects a real-time image of their location onto the skin. NEXT PAGE >> Related headlines Hoag expands service with Skylight extension Irvine’s Cardiogenesis submits device to FDA UCI study: Type two diabetics need specific treatment |
||||
